SCHEMBL30439149

SCHEMBL30439149

COc1nc(S(=O)(=O)N2CCCN(C(=O)OC(C)(C)C)CC2CCC(C)C)cc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 4/20 0.45
▸ MMP9 P14780 4/20 0.45
▸ MMP13 P45452 4/20 0.45
▸ HTR6 P50406 3/20 0.41
▸ MMP3 P08254 1/20 0.39
▸ MMP7 P09237 1/20 0.39
▸ ADAM17 P78536 1/20 0.37
▸ BCHE P06276 2/20 0.37
▸ TGFBR1 P36897 2/20 0.36
▸ GPR119 Q8TDV5 2/20 0.36
▸ APLNR P35414 1/20 0.35
▸ USP30 Q70CQ3 2/20 0.35
▸ BRD4 O60885 1/20 0.34
▸ HTR7 P34969 2/20 0.34
▸ HTR1A P08908 1/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ HTR1D P28221 1/20 0.34
▸ HTR1B P28222 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ HTR2C P28335 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30439166 0.90 MMP1 (0.47) MMP1MMP9MMP13HTR6MMP3
SCHEMBL23795385 0.85 MMP13 (0.41) MMP1MMP9MMP13HTR6MMP3
SCHEMBL24177988 0.85 MMP13 (0.41) MMP1MMP9MMP13HTR6MMP3
SCHEMBL30439034 0.80 MMP1 (0.35) MMP1MMP9MMP13HTR6HTR7
SCHEMBL30439444 0.79 MMP13 (0.43) MMP1MMP9MMP13HTR6MMP3
SCHEMBL30439332 0.76 MMP13 (0.45) MMP1MMP9MMP13HTR6MMP3
SCHEMBL23795403 0.74 MMP13 (0.43) MMP1MMP9MMP13HTR6MMP3
SCHEMBL24178165 0.74 MMP13 (0.43) MMP1MMP9MMP13HTR6MMP3
SCHEMBL30439175 0.74 MMP13 (0.43) MMP1MMP9MMP13HTR6MMP3
SCHEMBL30439085 0.70 CNR1 (0.45) MMP1MMP9MMP13HTR6MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111116555-B Rho kinase inhibitor and preparation method and application thereof 北京盈科瑞创新药物研究有限公司 2023-06-02 — — CN disclosed
Send feedback